about
Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerAtrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney CancerNivolumab and Ipilimumab in Treating Patients With Rare TumorsLung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching BiomarkersPegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerCombination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch RepairAtezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant MesotheliomaCisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung CancerErlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung CancerPomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple MyelomaPemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerFulvestrant and Bevacizumab in Treating Patients With Metastatic Breast CancerCitalopram in Treating Postmenopausal Women With Hot FlashesVitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for CancerTopical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for CancerRadiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent SurgeryA Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast CancerS0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast CancerSafety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)A Comparison of Narrow Band Imaging (NBI) and Standard White Light Laporoscopy to Detect EndometriosisA Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic ResponseGilead Sustained Virologic Response (SVR) RegistryEarly or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaFatigue Intervention Trial for Breast Cancer SurvivorsRuxolitinib Phosphate and Dasatinib or Nilotinib in Treating Patients With Chronic Myeloid LeukemiaBandGrip® Closure of Surgical Incisions Following Arthroscopic SurgeryGemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract CancersGenetic Analysis of Blood and Tissue Samples From Participants With Advanced CancerAn Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) InfectionB&O for TLH Post-operative Pain and NauseaQuality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast CancerCarboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by SurgerySiblings With Ischemic Stroke StudyS0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryComparison of Two Combination Chemotherapy Regimens in Treating Women With Breast CancerIxabepilone in Treating Patients With Metastatic Prostate CancerS0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AMLS0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck CancerFinancial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing TreatmentPembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
P6153
Q58407403-E7F3B217-DDB2-4956-B449-ED4438FAB9AFQ58407407-7294B78F-7BEC-4FC2-9584-1932D1B1342BQ58407779-ACD1C7A5-9405-4D15-B279-3EA3575BB315Q58407878-5AE4B924-1E84-470D-99AD-61E7D891D091Q58845627-5F1B9C1F-6911-4655-8F34-7F6FD888EB45Q58845885-9BB58135-8B5C-4570-84DE-D8F95C9ED0C3Q58846476-43DB1FA6-A4C0-427B-AF38-E9849A2945C4Q58846742-4480898F-8042-4E63-9253-84EDFC3D4BE5Q61713087-D22BF942-A1D8-4CED-A00B-16E45E84829FQ61864779-CFF5663F-17C7-4807-A0FD-F63BABFB8D34Q61920734-55B654CC-63F3-4D3E-A259-D65D39E78BC3Q61921646-73DEA1F0-EC3D-44DF-948F-482417081B12Q61934602-53FD16A5-AC7B-4C7E-BBA6-E601D90D5A37Q61934734-AF405EFD-EFBF-40A8-9405-26638F48D2B9Q61934755-2117B293-8AF3-457B-BD43-A6EA2784A933Q61936010-C2DC4158-120D-4231-85BE-B8A9EC7A619EQ61936011-7D8B80B6-D171-4332-BAFE-84F10FACFFEFQ61936449-8087D548-E540-4F74-85DC-5D8E0FF95D0EQ61936449-B19D31E8-3E37-4B90-87CE-1C7F4FE2A261Q61955365-A3963E2F-AA27-4E8A-B0FA-3614B5ABCD1BQ61956671-14C51C73-D5B3-4E50-96C0-05C721BFBB88Q61965936-87FF3B69-03D8-4DDC-87D8-6346A43392DCQ61965937-52981193-FB49-4CD5-A70A-C6779813F159Q61978936-73CCFBDB-7161-4D78-A0F5-D9EB1BF1DBFFQ61978982-4FFAE11A-122E-40BC-9390-8C52129E732FQ62025050-FA286155-EFB3-4515-A230-03C9E1A6365FQ62025916-E6D5B20B-51C8-46B9-BBD2-15752296F144Q62031551-0EBCA99C-5C76-4E7D-AE3C-038F36C86A9FQ62042674-F39766D9-C528-4CBC-BEB7-A40915FE547DQ62053968-96DB1182-F697-4E35-B414-11D99D77DCCBQ62062621-A9270E2B-ADE4-4919-B189-C723312E2128Q62104750-636F41E5-7111-4B83-948F-D4740BD41CC8Q62105307-B3A53A63-E53A-4C83-8D59-3584E5DC4E08Q62105410-AC85050A-4FA7-4B60-9E97-32C058692561Q62105820-3C41B514-516A-4AB9-9225-A7A94D50CED5Q62110429-AE381C1D-6087-4E34-B7FC-D94467BA5383Q62110433-87FC3168-CC29-4120-B958-A54D97E03D7BQ62110646-F32579D4-0C4E-48ED-A819-B2FA96D5A949Q62110754-ECC07C76-AEA1-473D-8544-7C9F425ADAA3Q62817334-BFE3C277-A888-4ABF-830C-05BC9499299B
P6153
description
healthcare organization in Canton, United States
@en
name
Mercy Medical Center
@en
type
label
Mercy Medical Center
@en
prefLabel
Mercy Medical Center
@en
P131
P213
0000 0004 0382 8575
P2427
grid.417043.5
P571
1911-01-01T00:00:00Z
P625
Point (-81.396269 40.812138)